Zogenix announced that the U.S. District Court in Massachusetts has entered an order preventing a ban on Zohydro ER on Constitutional grounds.
ImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2014 Financial ResultsBusiness Wire 04/17 16:20 ET
ImmunoGen, Inc. , a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that the Company will host a conference call at 8:00 a.m.
ImmunoGen, Inc. was a big mover last session, as the company saw its shares surge 11% on the day.
Apricus Biosciences, Inc. was a big mover last session, as the company saw its shares rise almost 19% on the day.
Pharmacyclics’ shares fell by nearly 8% yesterday, continuing its downtrend in the past one-month time frame.
ImmunoGen's shares have been up over a couple of trading sessions following positive pipeline results.
Forest Labs and partner Almirall announced that the FDA has provided a feedback on their new drug application (NDA) for the fixed dose combination of Tudorza (aclidinium) and formoterol.